Stay updated on SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    A new revision entry v3.5.0 was added to the record history. The previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:16:46.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the history. Revision: v3.4.2 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-12T03:02:51.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Added a new revision label (v3.4.2) to the record history and removed older notices (v3.4.1 and the funding-status notice). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-11T11:44:17.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    A government funding lapse notice was added and the record history shows a new Revision: v3.4.1 (replacing v3.4.0); these are administrative updates and do not affect core study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-04T10:25:00.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Added a glossary toggle and color-coded highlights for added/deleted items. Updated revision notes to v3.4.0 (replacing v3.3.4).
    Difference
    1%
    Check dated 2026-01-28T06:17:48.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Revision history updated to include v3.3.4 and remove v3.3.3 for the study NCT04293276.
    Difference
    0.1%
    Check dated 2026-01-14T02:34:53.000Z thumbnail image

Stay in the know with updates to SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page.